(in alphabetical order)

[1] M. H. Arons, C. J. Thynne, A. M. Grabrucker, D. Li, M. Schoen, J. E. Cheyne, T. M. Boeckers, J. M.
Montgomery, and C. C. Garner, “Autism-Associated Mutations in ProSAP2 / Shank3 Impair
Synaptic Transmission and Neurexin – Neuroligin-Mediated Transsynaptic Signaling”, J Neurosci,

[2] D. M. Cochoy, A. Kolevzon, Y. Kajiwara, M. Schoen, M. Pascual-Lucas, S. Lurie, J. D. Buxbaum, T. M.
Boeckers, and M. J. Schmeisser, “Phenotypic and functional analysis of SHANK3 stop mutations
identified in individuals with ASD and/or ID”, Mol. Autism, 2015.

[3] S. Cursano, C. R. Battaglia, C. Urrutia-Ruiz, S. Grabrucker, M. Schön, J. Bockmann, S. Braumüller , P. Radermacher, F. Roselli, M. Huber-Lang, T.M. Boeckers, “A CRHR1 antagonist prevents synaptic loss and memory deficits in a trauma-induced delirium-like syndrome”, Mol. Psychiatry, 2020.

[4] Y. C. Dai, H. F. Zhang, M. Schön, T. M. Böckers, S. P. Han, J. S. Han, R. Zhang, “Neonatal Oxytocin Treatment Ameliorates Autistic-Like Behaviors and Oxytocin Deficiency in Valproic Acid-Induced Rat Model of Autism”, Front. Cell. Neurosci., 2018.

[5] A. Dolnik, N. Kanwal, S. Mackert, S. Halbedl, C. Proepper, J. Bockmann, M. Schoen, T. M. Boeckers,
S. J. Kühl, and M. J. Schmeisser, “Sipa1l3/SPAR3 is targeted to postsynaptic specializations and
interacts with the Fezzin ProSAPiP1/Lzts3”, J. Neurochem., 2016.

[6] S. Grabrucker, J. C. Haderspeck, A. K. Sauer, N. Kittelberger, H. Asoglu, A. Abaei, V. Rasche, M. Schön, T. M. Boeckers, A. M. Grabrucker, “Brain Lateralization in Mice Is Associated with Zinc Signaling and Altered in Prenatal Zinc Deficient Mice That Display Features of Autism Spectrum Disorder”, Front. Mol. Neurosci., 2018.

[7] S. Grabrucker, J. Pagano, J. Schweizer, C. Urrutia-Ruiz, M. Schön, K. Thome, G. Ehret, A. M. Grabrucker, R. Zhang, B. Hengerer, J. Bockmann, C. Verpelli, C. Sala, T. M. Boeckers, “Activation of the medial preoptic area (MPOA) ameliorates loss of maternal behavior in a Shank2 mouse model for autism“, EMBO J., 2021.

[8] A. M. Grabrucker*, M. J. Schmeisser*, M. Schoen*, and T. M. Boeckers, “Postsynaptic ProSAP/Shank
scaffolds in the cross-hair of synaptopathies”, Trends Cell Biol., 2011.
* these authors contributed equally to this work

[9] A. M. Grabrucker, M. J. Schmeisser, P. T. Udvardi, M. Arons, M. Schoen, N. S. Woodling, K. I. Andreasson, P. R. Hof, J. D. Buxbaum, C. C. Garner, and T. M. Boeckers, “Amyloid beta protein-induced zinc sequestration leads to synaptic loss via dysregulation of the ProSAP2/Shank3 scaffold”, Mol. Neurodegener., 2011.

[10] S. Halbedl, M. Schoen, M. S. Feiler, T. M. Boeckers, and M. J. Schmeisser, “Shank3 is localized in
axons and presynaptic specializations of developing hippocampal neurons and involved in the
modulation of NMDA receptor levels at axon terminals”, J. Neurochem., 2016.

[11] C. Heise, J. C. Schroeder, M. Schoen, S. Halbedl, D. Reim, S. Woelfle, M. R. Kreutz, M. J. Schmeisser,
and T. M. Boeckers, “Selective Localization of Shanks to VGLUT1-Positive Excitatory Synapses in
the Mouse Hippocampus”, Front. Cell. Neurosci., 2016.

[12] J. Iaconisi, F. Hasselblatt, B. Mayer, M. Schoen, T.M. Böckers, A. Böckers, “Effects of an Educational Film About Body Donors on Students' Empathy and Anxiety Levels in Gross Anatomy.”, Anat. Sci. Educ., 2019.

[13] S. Jesse, J.P. Delling, M. Schön, T.M. Boeckers, A. Ludolph, M. Senel, “Phelan McDermid Syndrome: Multiple Sclerosis as a Rare but Treatable Cause for Regression-A Case Report”, Int. J. Mol. Sci., 2021.

[14] S. Liebau, C. Proepper, T. Schmidt, M. Schoen, J. Bockmann, and T. M. Boeckers, “ProSAPiP2, a
novel postsynaptic density protein that interacts with ProSAP2/Shank3”, Biochem. Biophys. Res.
Commun., 2009.

[15] S. Liebau, J. Steinestel, L. Linta, A. Kleger, A. Storch, M. Schoen, K. Steinestel, C. Proepper, J.
Bockmann, M. J. Schmeisser, and T. M. Boeckers, “An SK3 channel/nWASP/Abi-1 complex is
involved in early neurogenesis”, PLoS One, 2011.

[16] A. K. Lutz, S. Pfaender, B. Incearap, V. Ioannidis, I. Ottonelli, K. J. Föhr, J. Cammerer, M. Zoller, J. Higelin, F. Giona, M. Stetter, N. Stoecker, N. O. Alami, M. Schön, M. Orth, S. Liebau, G. Barbi, A. M. Grabrucker, R. Delorme, M. Fauler, B. Mayer , S. Jesse, F. Roselli, A. C. Ludolph, T. Bourgeron, C. Verpelli, M. Demestre, T. M. Boeckers, “Autism-associated SHANK3 mutations impair maturation of neuromuscular junctions and striated muscles.” Sci. Transl. Med., 2020.

[17] M. G. Mameza, E. Dvoretskova, M. Bamann, H. H. Hönck, T. Güler, T. M. Boeckers, M. Schoen, C.
Verpelli, C. Sala, I. Barsukov, A. Dityatev, and H. J. Kreienkamp, “SHANK3 gene mutations
associated with autism facilitate ligand binding to the SHANK3 ankyrin repeat region”, J. Biol.
Chem., 2013.

[18] S. Peykov, S. Berkel, M. Schoen, K. Weiss, F. Degenhardt, J. Strohmaier, B. Weiss, C. Proepper, G.
Schratt, M. M. Nöthen, T. M. Boeckers, M. Rietschel, and G. A. Rappold, “Identification and
functional characterization of rare SHANK2 variants in schizophrenia”, Mol. Psychiatry, 2015.

[19] C. Prelli Bozzo, R. Nchioua, M. Volcic, J. Krüger, S. Heller, C.M. Stürzel, D. Kmiec, C. Conzelmann, J. Müller, F. Zech, D. Schütz, L. Koepke, E. Braun, R. Groß, L. Wettstein, T. Weil, J. Weiß, D. Sauter, J. Münch, F. Diofano, C. Goffinet, A. Catanese, M. Schön, T. Böckers, S. Stenger, K. Sato, S. Just, A. Kleger, K. M. J. Sparrer, F. Kirchhoff, “IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition”, Nat. Comm., 2020.

[20] M. J. Schmeisser, S. J. Kühl, M. Schoen, N. H. Beth, T. M. Weis, A. M. Grabrucker, M. Kühl, and T. M.
Boeckers, “The Nedd4-binding protein 3 (N4BP3) is crucial for axonal and dendritic branching in
developing neurons”, Neural Dev., 2013.

[21] M. Schoen*, H. Asoglu*, H. F. Bauer, H.-P. Müller, A. Abaei, A. K. Sauer, R. Zhang, T.-J. Song, J. Bockmann, J. Kassubek, V. Rasche, A. M. Grabrucker, T. M. Boeckers, “Shank3 Transgenic and Prenatal Zinc-Deficient Autism Mouse Models Show Convergent and Individual Alterations of Brain Structures in MRI”, Front. Neural Circuits, 2019.
* these authors contributed equally to this work

[22] M. Schön, C. Lindenau, A. Böckers, C.-M. Altrock, L. Krys, A. Nosanova, N. Lang, A. Renz, J. Kroschel, E. Pensel, C. Grab, B. Mayer, D. A. C. Messerer, U. Fassnacht, J. P. Delling, M. Engelmann, A. Horneffer, M. Zernickel, K.-M. Debatin, J. Münch, F. Kirchhoff, T. Wirth, T. M. Boeckers, “Longitudinal SARS-CoV-2 infection study at Ulm University“, medRxiv, 2021.

[23] M. Schön, A. Nosanova, C. Jacob, J.M. Kraus, H.A.K. Kestler, B. Mayer, S. Feldengut, K. Amunts, K. Del Tredici, T. M. Boeckers,  H. Braak, “A comparative study of pre-alpha islands in the entorhinal cortex from selected primates and in lissencephaly“, J. Comp. Neurol., 2021.

[24] M. Schoen, J. M. Reichel, M. Demestre, S. Putz, D. Deshpande, C. Proepper, S. Liebau, M. J.
Schmeisser, A. C. Ludolph, J. Michaelis, and T. M. Boeckers, “Super-Resolution Microscopy Reveals
Presynaptic Localization of the ALS/FTD Related Protein FUS in Hippocampal Neurons”, Front. Cell.
Neurosci., 2016.

[25] M. Schön*, K. Steinestel*, D. Spiegelburg, A. Risch, M. Seidel, L. Schurr, U. K. Fassnacht, N. Golenhofen, T. M. Böckers, A. Böckers. “Integration of Scientific Competence into Gross Anatomy Teaching Using Poster Presentations: Feasibility and Perception among Medical Students“, Anat. Sci. Educ., 2020.
* these authors contributed equally to this work

[26] T. J. Song, X. Y. Lan, M. P. Wei, F. J. Zhai, T. M. Boeckers, J. N. Wang, S. Yuan, M. Y. Jin, Y. F. Xie, W. W. Dang, C. Zhang, M. Schön, P. W. Song, M. H. Qiu, Y. Y. Song, S. P. Han, J. S. Han, R. Zhang, “Altered Behaviors and Impaired Synaptic Function in a Novel Rat Model With a Complete Shank3 Deletion” Front. Cell. Neurosci., 2019.

[27] C. Verpelli, E. Dvoretskova, C. Vicidomini, F. Rossi, M. Chiappalone, M. Schoen, B. Di Stefano, R.
Mantegazza, V. Broccoli, T. M. Böckers, A. Dityatev, and C. Sala, “Importance of Shank3 protein in
regulating metabotropic glutamate receptor 5 (mGluR5) expression and signaling at synapses”, J.
Biol. Chem., 2011.